Low ceruloplasmin levels exacerbate retinal degeneration in a hereditary hemochromatosis model.
Anderson BD, Lee T, Bell B, Song Y, Dunaief JL.
Dis Model Mech. 2023 Jul 1;16(7):dmm050226. doi: 10.1242/dmm.050226. Epub 2023 Jul 13.
Progesterone anti-inflammatory properties in hereditary retinal degeneration.
Benlloch-Navarro S, Trachsel-Moncho L, Fernández-Carbonell Á, Olivar T, Soria JM, Almansa I, Miranda M.
J Steroid Biochem Mol Biol. 2019 May;189:291-301. doi: 10.1016/j.jsbmb.2019.01.007. Epub 2019 Jan 14.
Programmed Non-Apoptotic Cell Death in Hereditary Retinal Degeneration: Crosstalk between cGMP-Dependent Pathways and PARthanatos?
Yan J, Chen Y, Zhu Y, Paquet-Durand F.
Int J Mol Sci. 2021 Sep 29;22(19):10567. doi: 10.3390/ijms221910567.
Stem cells for treating retinal degeneration.
Busskamp V.
J Perinat Med. 2022 Dec 7;51(6):759-762. doi: 10.1515/jpm-2022-0510. Print 2023 Jul 26.
Revolution in evolution.
Honavar SG.
Indian J Ophthalmol. 2018 Dec;66(12):1667. doi: 10.4103/ijo.IJO_1894_18.
Light and inherited retinal degeneration.
Paskowitz DM, LaVail MM, Duncan JL.
Br J Ophthalmol. 2006 Aug;90(8):1060-6. doi: 10.1136/bjo.2006.097436. Epub 2006 May 17.
Gene therapy in hereditary retinal degeneration and the tower of Babel.
Pleyer U.
Br J Ophthalmol. 2001 Mar;85(3):255. doi: 10.1136/bjo.85.3.255.
[Survival factors in the treatment of hereditary retinal degeneration].
Frigg R, Wenzel A, Grimm C, Remé CE.
Ophthalmologe. 2005 Aug;102(8):757-63. doi: 10.1007/s00347-005-1244-0.
Wagner's hereditary vitreoretinal degeneration and retinal detachment.
Hirose T, Lee KY, Schepens CL.
Arch Ophthalmol. 1973 Mar;89(3):176-85. doi: 10.1001/archopht.1973.01000040178003.
[Retinal degeneration in patients with hereditary ceruloplasmin deficiency].
Yamaguchi K.
Nihon Naika Gakkai Zasshi. 2004 Aug 10;93(8):1591-6. doi: 10.2169/naika.93.1591.
